Wealth Enhancement Advisory Services LLC Has $425,000 Stake in ARK Genomic Revolution ETF $ARKG

Wealth Enhancement Advisory Services LLC cut its holdings in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 42.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 16,726 shares of the company’s stock after selling 12,203 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in ARK Genomic Revolution ETF were worth $425,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the company. DAVENPORT & Co LLC raised its holdings in shares of ARK Genomic Revolution ETF by 4.3% in the 1st quarter. DAVENPORT & Co LLC now owns 20,217 shares of the company’s stock worth $420,000 after buying an additional 838 shares in the last quarter. Oppenheimer & Co. Inc. acquired a new position in ARK Genomic Revolution ETF in the first quarter valued at about $387,000. Cambridge Investment Research Advisors Inc. boosted its position in shares of ARK Genomic Revolution ETF by 0.9% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 94,117 shares of the company’s stock worth $1,954,000 after purchasing an additional 839 shares in the last quarter. NBC Securities Inc. increased its stake in ARK Genomic Revolution ETF by 137,400.0% during the 1st quarter. NBC Securities Inc. now owns 1,375 shares of the company’s stock worth $28,000 after purchasing an additional 1,374 shares in the last quarter. Finally, LPL Financial LLC raised its stake in shares of ARK Genomic Revolution ETF by 13.4% in the 1st quarter. LPL Financial LLC now owns 783,702 shares of the company’s stock valued at $16,270,000 after purchasing an additional 92,444 shares during the period.

ARK Genomic Revolution ETF Stock Up 28.7%

ARK Genomic Revolution ETF stock opened at $30.40 on Tuesday. ARK Genomic Revolution ETF has a 1-year low of $17.51 and a 1-year high of $31.16. The company has a fifty day simple moving average of $25.61 and a 200 day simple moving average of $23.66.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.